• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Harbour BioMed

Colorful sailing boats at Fishermans Wharf of San Francisco Bay
Biotech

Otsuka's $670M pact to point Harbour's TCE to autoimmune disease

Aiming T-cell engagers at autoimmune diseases continues to be a red-hot dealmaking target.
James Waldron Jun 23, 2025 6:29am
Beijing International Trade CBD Building Complex China

AstraZeneca details $2.5B investment in China's political center

Mar 21, 2025 8:35am
boat cutting through water

Harbour launches obesity biotech on mission to preserve muscle

Mar 12, 2025 8:15am
Three blocks displaying from left to right a person a handshake and another person

Harbour spinoff pens $395M deal for preclinical Crenessity rival

Feb 26, 2025 5:14am
windmill turbines in the Netherlands

Windward generates $200M with Novo Holdings, OrbiMed in tow

Jan 10, 2025 10:02am
Deal terminate tear up end deal scrap

Cullinan, after $25M deal, hands back bispecific to Harbour

Aug 8, 2024 10:10am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings